Risk of alloreactivity after single HLA-mismatched haematopoietic stem cell transplantation increases with increasing numbers of predicted indirectly recognized HLA epitopes

被引：0
|
作者：
Thus, K. A. [1 ]
Calis, J. J. [2 ]
te Boome, L. [1 ]
Borst, E. [1 ]
Kesmir, C. [2 ]
Kuball, J. [1 ]
Spierings, E. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
[2] Univ Utrecht, Utrecht, Netherlands
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [21] Engraftment outcome of patients with anti-HLA antibodies in HLA-mismatched peripheral blood stem cell transplantation
    Hagino, Takeshi
    Ikegame, Kazuhiro
    Tanaka, Hidenori
    Kanda, Yoshinobu
    Kaida, Katsuji
    Fukuda, Takahiro
    Kondo, Yukio
    Sato, Maho
    Doki, Noriko
    Nakamae, Hirohisa
    Matsuoka, Ken-ichi
    Mori, Yasuo
    Sano, Hideki
    Eto, Tetsuya
    Kawakita, Toshiro
    Hashii, Yoshiko
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kanda, Junya
    HLA Working Grp Japanese Soc Transplantation Cellular Therapy
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, : 848 - 856
  • [22] Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors
    Koclega, Anna
    Markiewicz, Miroslaw
    Siekiera, Urszula
    Dobrowolska, Alicja
    Mizia, Sylwia
    Dzierzak-Mietla, Monika
    Zielinska, Patrycja
    Sobczyk-Kruszelnicka, Malgorzata
    Kyrcz-Krzemien, Slawomira
    BLOOD, 2012, 120 (21)
  • [23] Use of HLA-antibodies in flow cytometry for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation
    Schumm, M
    Lang, P
    Hoelle, W
    Kuci, S
    Ebinger, M
    Feuchtinger, T
    Handgretinger, R
    BONE MARROW TRANSPLANTATION, 2006, 37 : S211 - S211
  • [24] Complete resolution of Behcet's disease after HLA-mismatched allogeneic peripheral haematopoietic stem cell transplantation for myelodysplastic syndrome - case report
    Gopcsa, L.
    Barta, A.
    Torbagyi, E.
    Lengyel, L.
    Kallay, K.
    Rasonyi, R.
    Tremmel, A.
    Csomor, J.
    Kadar, J.
    Lueff, S.
    Krivan, G.
    BLOOD REVIEWS, 2007, 21 : S90 - S90
  • [25] Identifying Permissible HLA-Mismatches in Unrelated-Donor Hematopoietic Stem-Cell Transplantation Using Predicted Indirectly Recognizable HLA Epitopes
    Thus, Kirsten A.
    Geneugelijk, Kirsten
    van Deutekom, Hanneke
    Calis, Jorg
    Borst, Eric
    Kesmir, Can
    Oudshoorn, Machteld
    van der Holt, Bronno
    Meijer, Ellen
    Zeerleder, Sacha
    de Groot, Marco R.
    von dem Borne, Peter
    Schaap, Nicolaas
    Cornelissen, Jan
    Kuball, Jurgen
    Spierings, Eric
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S88 - S89
  • [26] HUMAN AND MOUSE SCID MODELS TO STUDY TOLERANCE AFTER HLA-MISMATCHED FETAL STEM-CELL TRANSPLANTATION
    BACCHETTA, R
    VANDEKERCKHOVE, BAE
    BIGLER, M
    RONCAROLO, MG
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 722 - 722
  • [27] Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies
    Huang, Wenrong
    Li, Honghua
    Gao, Chunji
    Bo, Jian
    Wang, Qunshun
    Zhao, Yu
    Jing, Yu
    Wang, Shuhong
    Zhu, Haiyan
    Dou, Liping
    Wang, Lili
    Yu, Li
    TRANSFUSION, 2012, 52 (06) : 1354 - 1362
  • [28] Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk haematologic malignancies
    Yu, L.
    Huang, W.
    Li, H.
    Gao, C.
    Bo, J.
    Wang, Q.
    Zhao, Y.
    Jing, Y.
    Wang, S.
    Zhu, H.
    Dou, L.
    Wang, L.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S291 - S291
  • [29] Successful Treatment of Hemorrhagic Cystitis After HLA-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation by Hyperbaric Oxygen
    Qian, Liren
    Shen, Jianliang
    Zhao, Defeng
    Pan, Shuyi
    TRANSPLANTATION, 2014, 97 (07) : E41 - E42
  • [30] Loss of mismatched HLA at leukaemia relapse after haematopoietic stem cell transplantation is significantly associated with clinical and immunogenetic hallmarks of donor-versus-host alloreactivity
    Crucitti, L.
    Crocchiolo, R.
    Toffalori, C.
    Stanghellini, M. T. Lupo
    Assanelli, A.
    Carrabba, M.
    Mazzi, B.
    Zino, E.
    Marktel, S.
    Marcatti, M.
    Corti, C.
    Bernardi, M.
    Peccatori, J.
    Bordignon, C.
    Bonini, C.
    Fleischhauer, K.
    Ciceri, F.
    Vago, L.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S249 - S249
12345